Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 572.60K | 520.60K | 559.50K | 426.50K | 472.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 572.60K | 520.60K | 559.50K | 426.50K | 472.70K |
| Cost of Revenue | 155.10K | 161.40K | 165.20K | 154.30K | 168.00K |
| Gross Profit | 417.50K | 359.20K | 394.30K | 272.20K | 304.70K |
| SG&A Expenses | 529.80K | 542.90K | 552.50K | 467.70K | 508.40K |
| Depreciation & Amortization | 15.30K | 7.70K | 31.60K | 51.80K | 71.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 700.30K | 712.00K | 749.30K | 673.80K | 747.60K |
| Operating Income | -127.70K | -191.40K | -189.80K | -247.40K | -275.10K |
| Income Before Tax | -161.30K | -223.20K | -236.90K | -295.70K | -337.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.16 | -0.22 | -0.24 | -0.30 | -0.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -161.30K | -223.20K | -236.90K | -295.70K | -337.70K |
| EBIT | -127.70K | -191.40K | -189.80K | -247.40K | -275.10K |
| EBITDA | -112.40K | -183.70K | -158.20K | -195.50K | -203.70K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 275.54M | 275.54M | 275.54M | 275.54M | 275.54M |
| Average Diluted Shares Outstanding | 275.54M | 275.54M | 275.54M | 275.54M | 275.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |